MedTrace Logo

Management of Recurrent Implantation Failure

NCT02681367 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2016-02-12

No results posted yet for this study

Summary

This is the first study to investigate, whether pregnancy and implantation rates would improve in patients with recurrent implantation failure (RIF), if all embryos were to be frozen and transferred in a consecutive natural cycle.

Conditions

  • Recurrent Implantation Failure (RIF)

Interventions

OTHER

Freeze all policy

Cryopreservation of human blastocysts for freeze all group has been employed using vitrification. The blastocysts were transferred after thawing in a frozen-thawed cycle.

Sponsors & Collaborators

  • TopLab Company for ART Laboratories Consultation and Training

    lead OTHER

Principal Investigators

  • Yasmin Magdi, M.Sc · Research and development department director at TopLab Company for ART laboratories consultations and training

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2016-01-31
Completion
2016-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02681367 on ClinicalTrials.gov